Advisor Group Holdings, Inc. Plus Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.46 - $1.02 $3,957 - $8,775	-8,603 Reduced 81.11%	2,003 $1,000
Q1 2022 May 04, 2022	BUY	$0.87 - $1.32 $1,392 - $2,113	1,601 Added 17.78%	10,606 $11,000
Q3 2021 Nov 05, 2021	BUY	$1.83 - $2.46 $1,830 - $2,460	1,000 Added 12.49%	9,005 $17,000
Q1 2021 May 13, 2021	BUY	$2.1 - $3.75 $4,204 - $7,507	2,002 Added 33.35%	8,005 $19,000
Q4 2020 Feb 10, 2021	BUY	$2.0 - $2.76 $4,998 - $6,897	2,499 Added 71.32%	6,003 $12,000
Q3 2020 Nov 12, 2020	BUY	$2.11 - $3.17 $7,385 - $11,095	3,500 Added 87500.0%	3,504 $9,000
Q1 2020 May 18, 2020	BUY	$1.05 - $2.85 $4 - $11	4 New	4 $0

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $36.6M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.